Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banna

Showing results (921-930 of 991) with videos related to

Pageof 100
Sort By:
Peerj|November 26, 2020
Tropical peatlands and their conservation are important in the context of COVID-19 and potential future (zoonotic) disease pandemicsMark E Harrison, Lahiru S Wijedasa, Lydia E S Cole, et al.
Seizure|March 19, 2019
Reliability of reported peri-ictal behavior to identify psychogenic nonepileptic seizuresWesley T Kerr, Andrea M Chau, Emily A Janio, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Scientific Reports|August 2, 2025
Dentists' role in oral care for head and neck cancer patients in GCC countriesBassel Tarakji, Anas B Alsalhani, Faisal Mehsen Alali, et al.
Future Oncology (London, England)|June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
BMC Pediatrics|October 19, 2023
Screening and determinant of suspected developmental delays among Egyptian preschool-aged children: a cross-sectional national community-based studyAmmal M Metwally, Ali M Abdallah, Ebtissam M Salah El-Din, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational studyTiziana Vavalà, Alessandro Follador, Marcello Tiseo, et al.
Future Oncology (London, England)|April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
ESMO Open|December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access ProgramS E Rebuzzi, A Signori, S Buti, et al.
Clinical Lung Cancer|June 25, 2017
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE StudySara Pilotto, Antonio Rossi, Tiziana Vavalà, et al.
Pageof 100

Showing results (921-930 of 991) with videos related to

Sort By:
Pageof 100
Peerj|November 26, 2020
Tropical peatlands and their conservation are important in the context of COVID-19 and potential future (zoonotic) disease pandemicsMark E Harrison, Lahiru S Wijedasa, Lydia E S Cole, et al.
Seizure|March 19, 2019
Reliability of reported peri-ictal behavior to identify psychogenic nonepileptic seizuresWesley T Kerr, Andrea M Chau, Emily A Janio, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Scientific Reports|August 2, 2025
Dentists' role in oral care for head and neck cancer patients in GCC countriesBassel Tarakji, Anas B Alsalhani, Faisal Mehsen Alali, et al.
Future Oncology (London, England)|June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
BMC Pediatrics|October 19, 2023
Screening and determinant of suspected developmental delays among Egyptian preschool-aged children: a cross-sectional national community-based studyAmmal M Metwally, Ali M Abdallah, Ebtissam M Salah El-Din, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational studyTiziana Vavalà, Alessandro Follador, Marcello Tiseo, et al.
Future Oncology (London, England)|April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
ESMO Open|December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access ProgramS E Rebuzzi, A Signori, S Buti, et al.
Clinical Lung Cancer|June 25, 2017
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE StudySara Pilotto, Antonio Rossi, Tiziana Vavalà, et al.
Pageof 100